USX:HSKA - Heska Corp. (USD 64.83) Heska Corp.
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 64.83    +3.870 (+6.35%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


Overview

9 Apr 2020

Day Change: 3.870 (6.35%)

52 Wk Range: 50.0 - 110.9

Day's Range: 62.435 - 65.77

Last Volume: 46,041

Current Yield: 0%

Projected Yield: 0%

Open: USD 62.45

9 Apr 2020

Metric HSKA S.Median
Beta 0.99 0.84
VaR 30.46 25.23
E.Shortfall 51.2 45.03
Liquidity 68.98K 95.2K

Fundamental

9 Apr 2020

PE: -278.87

Market Cap: 482.7M

Price Over Book: 3.127

Price Over Sales: 3.94

Return On Assets: -0.7%

Return On Equity: -1.1%

Price Over NAV: [Friends Only]

General

CEO: Kevin S. Wilson

Headquarters: LOVELAND

Employees: 347

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. It operates through two segments, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus Chewable Tablets for the preventive treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels. The Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. The company sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.